Calidi Biotherapeutics, Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 320703309 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Armistice Capital, LLC 13G Amended under CUSIP 320703408 on 8/14/2025	10.0%	3,359,661	13G	5/15/2025 Event 3/31/2025
Armistice Capital, LLC	10.0%	3,359,661
Steven Boyd	10.0%	3,359,661

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q3	2	21.1 k	$31.8 k	$0
2025 Q2	37	2.86 M	$657 k	$0
2025 Q1	38	5.46 M	$3.09 M	$8.81 k
2024 Q4	34	1.10 M	$1.27 M	$0
2024 Q3	21	319 k	$363 k	$0
2024 Q2	2	157 k	$31.3 k	$0